List of Excipients in API conjugated estrogens/bazedoxifene
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing conjugated estrogens/bazedoxifene
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | DUAVEE | conjugated estrogens/bazedoxifene | 0008-1123 | ASCORBIC ACID | 2027-03-10 |
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | DUAVEE | conjugated estrogens/bazedoxifene | 0008-1123 | CELLULOSE, MICROCRYSTALLINE | 2027-03-10 |
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | DUAVEE | conjugated estrogens/bazedoxifene | 0008-1123 | FERRIC OXIDE RED | 2027-03-10 |
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | DUAVEE | conjugated estrogens/bazedoxifene | 0008-1123 | FERRIC OXIDE YELLOW | 2027-03-10 |
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | DUAVEE | conjugated estrogens/bazedoxifene | 0008-1123 | FERROSOFERRIC OXIDE | 2027-03-10 |
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | DUAVEE | conjugated estrogens/bazedoxifene | 0008-1123 | HYDROXYETHYL CELLULOSE | 2027-03-10 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for conjugated estrogens/bazedoxifene
Excipient focus: ASCORBIC ACID
conjugated estrogens/bazedoxifene drug variants containing ASCORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing ASCORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
conjugated estrogens/bazedoxifene drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
conjugated estrogens/bazedoxifene drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
conjugated estrogens/bazedoxifene drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
conjugated estrogens/bazedoxifene drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYL CELLULOSE
conjugated estrogens/bazedoxifene drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
conjugated estrogens/bazedoxifene drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2208
conjugated estrogens/bazedoxifene drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
conjugated estrogens/bazedoxifene drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
conjugated estrogens/bazedoxifene drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
conjugated estrogens/bazedoxifene drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MALTITOL
conjugated estrogens/bazedoxifene drug variants containing MALTITOL
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing MALTITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 188
conjugated estrogens/bazedoxifene drug variants containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYDEXTROSE
conjugated estrogens/bazedoxifene drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
conjugated estrogens/bazedoxifene drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
conjugated estrogens/bazedoxifene drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POWDERED CELLULOSE
conjugated estrogens/bazedoxifene drug variants containing POWDERED CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing POWDERED CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
conjugated estrogens/bazedoxifene drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
conjugated estrogens/bazedoxifene drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE PALMITATE
conjugated estrogens/bazedoxifene drug variants containing SUCROSE PALMITATE
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing SUCROSE PALMITATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
conjugated estrogens/bazedoxifene drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIBASIC CALCIUM PHOSPHATE
conjugated estrogens/bazedoxifene drug variants containing TRIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc | conjugated estrogens/bazedoxifene | 0008-1123 |
| US Pharmaceuticals | conjugated estrogens/bazedoxifene | 63539-122 |
| >Company | >Ingredient | >NDC |
conjugated estrogens/bazedoxifene drug variants not containing TRIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
